Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1b Study of IC14 in Arrhythmogenic Cardiomyopathy

NCT06275893 is registered in ClinicalTrials.gov with Implicit Bioscience as lead sponsor.

NCT NCT06275893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06275893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1b Study of IC14 in Arrhythmogenic Cardiomyopathy
Lead sponsor
Implicit Bioscience
Phase
Phase 1/2
Overall status
Completed
Start date
March 29, 2024
Completion date
April 15, 2026
Enrollment
1 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acm, arrhythmogenic cardiomyopathy, arrhythmogenic left ventricular cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy 1, arrhythmogenic right ventricular dysplasia, arvc, pkp2